The Norwegian Dry Eye Clinic Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2017
NCT03318874
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

The Norwegian Dry Eye Clinic

Active Ingredients

Drugs in Phase 4 Trials (1)

hyaluronic acid (2 trials)

Drugs in Other Trials (1)

trehalose (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dry Eye Syndromes (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2